Home Obi Profile Fees Services News Publications Contact  
You are here: Title Details
Search  
    Login
Inventions Industrial DesignTechnological Information
Human monoclonal antibodies to programmed death 1(PD-1) and methods for treating cancer using anti-PD-1 antibodies alone or in combination with other immunotherapeutics

No-Receipt date 2019-01847 - 15/05/2019
No-Filing date 20190401460 - 15/05/2019
No-Granting date 3100325 - 23/07/2019
No-EPO application date 11178191.0 - 02/05/2006
No-EPO granting date 2439273 - 27/02/2019
Gazette No-Publication date of application -
Gazette No-Publication date of granted patent 7/2019 - 06/09/2019
Expiration date 03/05/2026
Kind of title Validation of European Patent
Legal status NOT VALID
Priorities US679466 P09/05/2005/US
US738434 P21/11/2005/US
US748919 P08/12/2005/US
Active Substance of Supplementary Certificates -

IPC Classification
Ipc Class
C12Q 1/02
C12P 21/08
C12N 5/00
C12N 15/09
C07K 16/28

Related Documents

Related Titles

Owners
CodeFirstnameSurnameAddressTownZIPCountry
1011208 ONO PHARMACEUTICAL CO., LTD. 1-5, DOSHOMACHI 2-CHOME CHUO-KUOSAKA-SHI, OSAKA 541-8526 JAPAN
1011209 E. R. SQUIBB & SONS, L.L.C. ROUTE 206 & PROVINCE LINE ROADPRINCETON, NJ 08540 UNITED STATES OF AMERICA (USA)

Inventors
CodeFirstnameSurname
2539882 SRINIVASAN, MOHAN
2539883 WANG, CHANGYU
2539884 SELBY, MARK, J.
2539885 CHEN, BING
2539886 CARDARELLI, JOSEPHINE, M.
2539887 KORMAN, ALAN, J.
2539888 HUANG, HAICHUN

Representatives
CodeFirstnameSurnameAddressTownZip
3554ANTHOULAGALANOPOULOUDIONYSOU 68MAROUSI (ATTIKIS)15124

Contact
CodeFirstnameSurnameAddressTownZipCountry
2897ALKISTIS-EIRINIMALAMISKOUFA 52ATHINA (ATTIKIS)10672 GREECE

Owners History

Title Instruments

Payments history 14 renewals have been done
Print
Dues Online PaymentNational Patent RegisterOne Stop Shop (OSS)
© OBI all rights reserved designed & developed by PROFILE S.A.
Certified QMS : EN ISO 9001:2015 and ΕΝ ISO 14001:2015
 
The project "Internet technological information diffusion from industrial property titles" is co-financed 70% by the European Regional Development Found and 30% by the Hellenic public sector (Operational programme "Competitiveness", Measure 4.4).